{"classes":[{"categories":[{"measurements":[{"comment":"Median and upper limit of 95% CI was not estimable due to short follow-up by participants\".","groupId":"OG000","lowerLimit":"15.21","upperLimit":"NA","value":"NA"},{"groupId":"OG001","lowerLimit":"8.31","upperLimit":"24.80","value":"15.90"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"71"}],"units":"Participants"}],"description":"Duration of response will be restricted to the randomized subjects who achieve a best objective response of PR or better. It is measured from the time, in months, that the criteria for objective response are first met until the date of a progression event (according to the primary definition of PFS).","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients received Daratumumab subcutaneously (fixed dose of 1800 mg) or intravenously (16 mg/kg) weekly for cycles 1-2, every 2 weeks for cycles 3-6, and every 4 weeks thereafter. Pomalidomide was administered at a dose of 4 mg orally every day on days 1 through 21, and dexamethasone at 40 mg (or 20 mg for patients ≥75 years of age) orally weekly, in 28-day cycles..\n\nPomalidomide: Pomalidomide will be administered at full dose of 4 mg orally (PO) on Days 1 through 21 of each 28-day cycle.\n\nDexamethasone: Dexamethasone will be administered at a dose of 40 mg (20 mg for patients ≥75 years of age) orally, once daily on Days 1, 8, 15, and 22 of each 28-day treatment cycle.","id":"OG000","title":"Daratumumab+Pomalidomide+Dexamethasone"},{"description":"Patients received Pomalidomide at a dose of 4 mg orally every day on days 1 through 21, and dexamethasone 40 mg (or 20 mg for patients ≥75 years of age) orally weekly, in 28-day cycles","id":"OG001","title":"Pomalidomide + Dexamethasone"}],"paramType":"MEDIAN","populationDescription":"Subjects achieving a best objective response of PR or better from the intention-to-treat population.","reportingStatus":"POSTED","timeFrame":"From informed consent until 30 days after last study treatment, assessed up to approximately 3 years.","title":"Duration of Response","type":"SECONDARY","unitOfMeasure":"months"}